منابع مشابه
Bromocriptine in mania--a placebo-controlled double-blind trial.
3Nielsen MS, Manners JM. Valve replacement in carcinoid syndrome. Anaesthesia 1979;34:494-9. 4Chatterjee K, Heather LC. Carcinoid heart disease from primary ovarian carcinoid tumors. Am Y Med 1968;45 :643-8. 5 Herreman F, Vernant P, Cachera JP, Monier Ph. Insuffisance tricuspidienne severe et tumeur carcin6ide primitive de l'ovaire. Succes du remplacement valvulaire a long terme. Arch Mal Coeur...
متن کاملPatterns of response to aripiprazole, lithium, haloperidol, and placebo across factor scores of mania
BACKGROUND A previous factor analysis of Young Mania Rating Scale and Montgomery-Åsberg Depression Rating Scale items identified composite factors of depression, mania, sleep disturbance, judgment/impulsivity, and irritability/hostility as major components of psychiatric symptoms in acute mania or mixed episodes in a series of trials of antipsychotics. However, it is unknown whether these facto...
متن کاملFactors modifying drug and placebo responses in randomized trials for bipolar mania.
Randomized placebo-controlled trials (RCTs) are standard for assessing efficacy and safety of treatments. We pursued preliminary indications that some factors are associated differentially with responses to placebo or drugs in RCTs for bipolar mania. We meta-analysed data from RCTs to assess influences of study-site count, subjects' age, sex distribution, diagnostic subgroups, clinical features...
متن کاملBlue‐blocking glasses as additive treatment for mania: a randomized placebo‐controlled trial
OBJECTIVES The discovery of the blue lightsensitive retinal photoreceptor responsible for signaling daytime to the brain suggested that light to the circadian system could be inhibited by using blue-blocking orange tinted glasses. Blue-blocking (BB) glasses are a potential treatment option for bipolar mania. We examined the effectiveness of BB glasses in hospitalized patients with bipolar disor...
متن کاملAripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study.
BACKGROUND Well-tolerated and effective therapies for bipolar mania are required. AIMS To evaluate the efficacy and tolerability of aripiprazole as acute and maintenance of effect therapy in patients with bipolar I disorder experiencing manic or mixed episodes. METHOD Patients were randomised to double-blind aripiprazole (15 or 30 mg/day; n=167), placebo (n=153) or haloperidol (5-15 mg/day,...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1996
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.313.7063.1008a